SAVE 40% ON SINGLE IMAGE PURCHASES - OFFER ENDS SOON, USE CODE: SAVEIMAGE40%
Page 1 of 1
Ceo of schering ag Stock Photos and Images
Hubertus Erlen, the CEO of Schering AG, talks to journalists at the company's headquarters in Berlin, Tuesday 14 March 2006. Schering's supervisory board rejected the take over bid by its competitor Merck. The supervisory board agrees with the stand of the board of managing directors and opinions that the take over bid by Merck does not correspond with the value of Schering said E Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-hubertus-erlen-the-ceo-of-schering-ag-talks-to-journalists-at-the-53927393.htmlRMD3MGX9–Hubertus Erlen, the CEO of Schering AG, talks to journalists at the company's headquarters in Berlin, Tuesday 14 March 2006. Schering's supervisory board rejected the take over bid by its competitor Merck. The supervisory board agrees with the stand of the board of managing directors and opinions that the take over bid by Merck does not correspond with the value of Schering said E
Hubertus Erlen Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-hubertus-erlen-111821568.htmlRMGDWWFC–Hubertus Erlen
Hubertus Erlen, the CEO of Schering AG, talks to journalists at the company's headquarters in Berlin, Tuesday 14 March 2006. Schering's supervisory board rejected the take over bid by its competitor Merck. The supervisory board agrees with the stand of the board of managing directors and opinions that the take over bid by Merck does not correspond with the value of Schering said E Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-hubertus-erlen-the-ceo-of-schering-ag-talks-to-journalists-at-the-53927394.htmlRMD3MGXA–Hubertus Erlen, the CEO of Schering AG, talks to journalists at the company's headquarters in Berlin, Tuesday 14 March 2006. Schering's supervisory board rejected the take over bid by its competitor Merck. The supervisory board agrees with the stand of the board of managing directors and opinions that the take over bid by Merck does not correspond with the value of Schering said E
Hubertus Erlen Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-hubertus-erlen-111821573.htmlRMGDWWFH–Hubertus Erlen
Hubertus Erlen, the CEO of Schering AG, talks to journalists at the company's headquarters in Berlin, Tuesday 14 March 2006. Schering's supervisory board rejected the take over bid by its competitor Merck. The supervisory board agrees with the stand of the board of managing directors and opinions that the take over bid by Merck does not correspond with the value of Schering said E Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-hubertus-erlen-the-ceo-of-schering-ag-talks-to-journalists-at-the-53927395.htmlRMD3MGXB–Hubertus Erlen, the CEO of Schering AG, talks to journalists at the company's headquarters in Berlin, Tuesday 14 March 2006. Schering's supervisory board rejected the take over bid by its competitor Merck. The supervisory board agrees with the stand of the board of managing directors and opinions that the take over bid by Merck does not correspond with the value of Schering said E
Hubertus Erlen Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-hubertus-erlen-111821572.htmlRMGDWWFG–Hubertus Erlen
Hubertus Erlen, the CEO of Schering AG leaves the room after he made a statement at the company's headquarters in Berlin, Tuesday 14 March 2006. Schering's supervisory board rejected the take over bid by its competitor Merck. The supervisory board agrees with the stand of the board of managing directors and opinions that the take over bid by Merck does not correspond with the valu Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-hubertus-erlen-the-ceo-of-schering-ag-leaves-the-room-after-he-made-53927397.htmlRMD3MGXD–Hubertus Erlen, the CEO of Schering AG leaves the room after he made a statement at the company's headquarters in Berlin, Tuesday 14 March 2006. Schering's supervisory board rejected the take over bid by its competitor Merck. The supervisory board agrees with the stand of the board of managing directors and opinions that the take over bid by Merck does not correspond with the valu
Wenning and Erlen Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-wenning-and-erlen-111821576.htmlRMGDWWFM–Wenning and Erlen
Hubertus Erlen, the CEO of Schering AG leaves the room after he made a statement at the company's headquarters in Berlin, Tuesday 14 March 2006. Schering's supervisory board rejected the take over bid by its competitor Merck. The supervisory board agrees with the stand of the board of managing directors and opinions that the take over bid by Merck does not correspond with the valu Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-hubertus-erlen-the-ceo-of-schering-ag-leaves-the-room-after-he-made-53927396.htmlRMD3MGXC–Hubertus Erlen, the CEO of Schering AG leaves the room after he made a statement at the company's headquarters in Berlin, Tuesday 14 March 2006. Schering's supervisory board rejected the take over bid by its competitor Merck. The supervisory board agrees with the stand of the board of managing directors and opinions that the take over bid by Merck does not correspond with the valu
Wenning and Erlen Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-wenning-and-erlen-111821575.htmlRMGDWWFK–Wenning and Erlen
CEO of German chemical and pharmaceutical company Bayer AG, Werner Wenning, is pictured at Bayer Schering Pharma in Berlin, Germany, 15 September 2008. Photo: Peer Grimm Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-ceo-of-german-chemical-and-pharmaceutical-company-bayer-ag-werner-54442911.htmlRMD4G2DK–CEO of German chemical and pharmaceutical company Bayer AG, Werner Wenning, is pictured at Bayer Schering Pharma in Berlin, Germany, 15 September 2008. Photo: Peer Grimm
Wenning and Erlen Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-wenning-and-erlen-111821569.htmlRMGDWWFD–Wenning and Erlen
CEO of German chemical and pharmaceutical company Bayer AG, Werner Wenning, is pictured at Bayer Schering Pharma in Berlin, Germany, 15 September 2008. Photo: Peer Grimm Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-ceo-of-german-chemical-and-pharmaceutical-company-bayer-ag-werner-54442912.htmlRMD4G2DM–CEO of German chemical and pharmaceutical company Bayer AG, Werner Wenning, is pictured at Bayer Schering Pharma in Berlin, Germany, 15 September 2008. Photo: Peer Grimm
Werner Wenning (R), chairman of the Bayer Schering Pharma AG supervisory board, and CEO Arthur Higgins chat during the pharmaceutical company' general meeting in Berlin, Germany, 16 May 2008. Photo: WOLFGANG KUMM Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-werner-wenning-r-chairman-of-the-bayer-schering-pharma-ag-supervisory-54398350.htmlRMD4E1J6–Werner Wenning (R), chairman of the Bayer Schering Pharma AG supervisory board, and CEO Arthur Higgins chat during the pharmaceutical company' general meeting in Berlin, Germany, 16 May 2008. Photo: WOLFGANG KUMM
Wenning and Erlen Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-wenning-and-erlen-111821574.htmlRMGDWWFJ–Wenning and Erlen
Werner Wenning (L), chairman of the Bayer Schering Pharma AG supervisory board, and CEO Arthur Higgins chat during the pharmaceutical company' general meeting in Berlin, Germany, 16 May 2008. Photo: WOLFGANG KUMM Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-werner-wenning-l-chairman-of-the-bayer-schering-pharma-ag-supervisory-54398353.htmlRMD4E1J9–Werner Wenning (L), chairman of the Bayer Schering Pharma AG supervisory board, and CEO Arthur Higgins chat during the pharmaceutical company' general meeting in Berlin, Germany, 16 May 2008. Photo: WOLFGANG KUMM
Bayer AG CEO Werner Wenning smiles at his company's autumn press conference in Leverkusen, Germany, Monday, 27 November 2006. Third-quarter sales increase by 26 percent to 7.783 billion euro. The acquisition of Schering pushed the good results. Photo: Achim Scheidemann Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-bayer-ag-ceo-werner-wenning-smiles-at-his-companys-autumn-press-conference-54022592.htmlRMD3TXA8–Bayer AG CEO Werner Wenning smiles at his company's autumn press conference in Leverkusen, Germany, Monday, 27 November 2006. Third-quarter sales increase by 26 percent to 7.783 billion euro. The acquisition of Schering pushed the good results. Photo: Achim Scheidemann
Wenning and Erlen Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-wenning-and-erlen-111821562.htmlRMGDWWF6–Wenning and Erlen
Bayer AG CEO Werner Wenning arrives at his company's autumn press conference in Leverkusen, Germany, Monday, 27 November 2006. Third-quarter sales increase by 26 percent to 7.783 billion euro. The acquisition of Schering pushed the good results. Photo: Achim Scheidemann Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-bayer-ag-ceo-werner-wenning-arrives-at-his-companys-autumn-press-conference-54022607.htmlRMD3TXAR–Bayer AG CEO Werner Wenning arrives at his company's autumn press conference in Leverkusen, Germany, Monday, 27 November 2006. Third-quarter sales increase by 26 percent to 7.783 billion euro. The acquisition of Schering pushed the good results. Photo: Achim Scheidemann
Wenning and Erlen Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-wenning-and-erlen-111821561.htmlRMGDWWF5–Wenning and Erlen
CEO of Bayer AG Werner Wenning gestures at his company's autumn press conference in Leverkusen, Germany, Monday, 27 November 2006. Third-quarter sales increase by 26 percent to 7.783 billion euro. The acquisition of Schering pushed the good results. Photo: Achim Scheidemann Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-ceo-of-bayer-ag-werner-wenning-gestures-at-his-companys-autumn-press-54022634.htmlRMD3TXBP–CEO of Bayer AG Werner Wenning gestures at his company's autumn press conference in Leverkusen, Germany, Monday, 27 November 2006. Third-quarter sales increase by 26 percent to 7.783 billion euro. The acquisition of Schering pushed the good results. Photo: Achim Scheidemann
Chemical and pharmaceuticals giant Bayer AG CEO Werner Wenning is pictured during the annual balance press conference in Leverkusen, Germany, Thursday, 15 March 2007. Thanks to stable business activities and the takeover of the Schering AG Bayer was able to increase its operational profit in 2006 distinctively. Photo: Oliver Berg Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-chemical-and-pharmaceuticals-giant-bayer-ag-ceo-werner-wenning-is-58333589.htmlRMDAW92D–Chemical and pharmaceuticals giant Bayer AG CEO Werner Wenning is pictured during the annual balance press conference in Leverkusen, Germany, Thursday, 15 March 2007. Thanks to stable business activities and the takeover of the Schering AG Bayer was able to increase its operational profit in 2006 distinctively. Photo: Oliver Berg
Wenning and Erlen Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-wenning-and-erlen-111821564.htmlRMGDWWF8–Wenning and Erlen
Chemical and pharmaceuticals giant Bayer AG CEO Werner Wenning is pictured during the annual balance press conference in Leverkusen, Germany, Thursday, 15 March 2007. Thanks to stable business activities and the takeover of the Schering AG Bayer was able to increase its operational profit in 2006 distinctively. Photo: Oliver Berg Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-chemical-and-pharmaceuticals-giant-bayer-ag-ceo-werner-wenning-is-58333590.htmlRMDAW92E–Chemical and pharmaceuticals giant Bayer AG CEO Werner Wenning is pictured during the annual balance press conference in Leverkusen, Germany, Thursday, 15 March 2007. Thanks to stable business activities and the takeover of the Schering AG Bayer was able to increase its operational profit in 2006 distinctively. Photo: Oliver Berg
Arthur J. Higgins, Scottish CEO of Bayer Schering Pharma AG shown in front of the company logo at the extraordinary general meeting of the company in Berlin, Wednesday, 17 January 2007. Bayer had taken over Schering in September, thus becoming the Bayer Schering AG, which is now the largest German chemical and pharmaceutical company. Photo: Rainer Jensen Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-arthur-j-higgins-scottish-ceo-of-bayer-schering-pharma-ag-shown-in-54030202.htmlRMD3W822–Arthur J. Higgins, Scottish CEO of Bayer Schering Pharma AG shown in front of the company logo at the extraordinary general meeting of the company in Berlin, Wednesday, 17 January 2007. Bayer had taken over Schering in September, thus becoming the Bayer Schering AG, which is now the largest German chemical and pharmaceutical company. Photo: Rainer Jensen
Wenning and Erlen Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-wenning-and-erlen-111821563.htmlRMGDWWF7–Wenning and Erlen
Hubertus Erlen Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-hubertus-erlen-111803281.htmlRMGDW269–Hubertus Erlen
Arthur J. Higgins, Scottish CEO of Bayer Schering Pharma AG shown in front of the company logo at the extraordinary general meeting of the company in Berlin, Wednesday, 17 January 2007. Bayer had taken over Schering in September, thus becoming the Bayer Schering AG, which is now the largest German chemical and pharmaceutical company. Photo: Rainer Jensen Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-arthur-j-higgins-scottish-ceo-of-bayer-schering-pharma-ag-shown-in-54030201.htmlRMD3W821–Arthur J. Higgins, Scottish CEO of Bayer Schering Pharma AG shown in front of the company logo at the extraordinary general meeting of the company in Berlin, Wednesday, 17 January 2007. Bayer had taken over Schering in September, thus becoming the Bayer Schering AG, which is now the largest German chemical and pharmaceutical company. Photo: Rainer Jensen
Hubertus Erlen Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-hubertus-erlen-111803282.htmlRMGDW26A–Hubertus Erlen
Werner Wenning Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-werner-wenning-111821570.htmlRMGDWWFE–Werner Wenning
Arthur J. Higgins, Scottish CEO of Bayer Schering Pharma AG shown with folded hands in front of the company logo at the extraordinary general meeting of the company in Berlin, Wednesday, 17 January 2007. Bayer had taken over Schering in September, thus becoming the Bayer Schering AG, which is now the largest German chemical and pharmaceutical company. Photo: Rainer Jensen Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-arthur-j-higgins-scottish-ceo-of-bayer-schering-pharma-ag-shown-with-54030208.htmlRMD3W828–Arthur J. Higgins, Scottish CEO of Bayer Schering Pharma AG shown with folded hands in front of the company logo at the extraordinary general meeting of the company in Berlin, Wednesday, 17 January 2007. Bayer had taken over Schering in September, thus becoming the Bayer Schering AG, which is now the largest German chemical and pharmaceutical company. Photo: Rainer Jensen
Werner Wenning Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-werner-wenning-111821571.htmlRMGDWWFF–Werner Wenning
Werner Wenning, supervisory board chairman of Bayer Schering Pharma AG holds a speech behind CEO Arthur J. Higgins (bottom) at the extraordinary general meeting of the company in Berlin, Wednesday, 17 January 2007. Bayer had taken over Schering in September, thus becoming the Bayer Schering AG, which is now the largest German chemical and pharmaceutical company. Photo: Rainer Jense Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-werner-wenning-supervisory-board-chairman-of-bayer-schering-pharma-54030204.htmlRMD3W824–Werner Wenning, supervisory board chairman of Bayer Schering Pharma AG holds a speech behind CEO Arthur J. Higgins (bottom) at the extraordinary general meeting of the company in Berlin, Wednesday, 17 January 2007. Bayer had taken over Schering in September, thus becoming the Bayer Schering AG, which is now the largest German chemical and pharmaceutical company. Photo: Rainer Jense
Werner Wenning Stock Photohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-werner-wenning-111821565.htmlRMGDWWF9–Werner Wenning
Search Results for Ceo of schering ag Stock Photos and Images (36)
Page 1 of 1